Source: Virtual Congress 2020 – Translational science in respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
R. Razumnyi (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine). Condition of cellular immunity in patients with prolonged course of community acquired pneumonia. 2328

Member's Comments

No comment yet.

Related content which might interest you: Clinical presentation and evolution of community acquired pneumonia in older patients Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Features of community acquired pneumonia in patients hospitalized in the institute for pulmonary diseases over a five-year period Source: Eur Respir J 2006; 28: Suppl. 50, 165s Year: 2006 The usage of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 579s Year: 2005 Differences between local and systemic inflammatory response in patients with community acquired pneumonia (CAP) Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 The role of procoagulant activity in patients with community acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Imaging patterns of bacterial community acquired pneumonia in moderately immunocompromised patients Source: Annual Congress 2009 - Old and new: technique and pathology Year: 2009 Determinants of vaccination in patients with community acquired pneumonia (CAP) or chronic lung diseases Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence Year: 2004 Community acquired pneumonia in COPD patients: ?linical features and peculiarities of immune system Source: International Congress 2019 – Airway infection in COPD Year: 2019 Evaluation of clinical efficiency of thiotriazolin in complex treatment of patients with community acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 669s Year: 2006 A prospective comparison of nursing home acquired pneumonia with community acquired pneumonia Source: Eur Respir J 2001; 18: 362-368 Year: 2001 Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia Year: 2007 Assessment of humoral immune response and the incidence of acquired infections in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 174s Year: 2003 Using roncoleukine in basic therapy of patients with community acquired pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002 Epidemiology, antimicrobial resistance and clinical outcomes in nursing home associated pneumonia compared to community acquired pneumonia Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Frequency of antibiotic resistance and outcomes in severe community acquired pneumonia due to Streptococcus pneumoniae Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Postexpiratory pause reflects breathing control in patients with community acquired pneumonia Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Viral infection in adult hospitalized with community acquired pneumonia Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects Year: 2010 Influence of medical comorbidities in patients with community acquired pneumonia Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools Year: 2010 Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Virusologic research in healthy persons of closed collectives Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections Year: 2005